New

Acute Lymphocytic Leukemia Market

2021

Acute Lymphocytic Leukemia Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (B-cell, T-cell); Therapy (Chemotherapy, Radiation Therapy, Bone Marrow Transplant, Targeted Therapy, Immunotherapy); Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Geography

| Report Code: TIPRE00004060 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Acute Lymphocytic Leukemia Market 2028 By Type, Therapy, Distribution Channel and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



ALL (lymphoblastic/lymphocytic leukaemia) is a malignancy that arises from immature lymphocytes. The term ""acute"" refers to leukaemia that progresses quickly and spreads throughout the body. ALL begins in the bone marrow and quickly invades to the liver, spleen, lymph nodes, liver, central nervous system, spleen, central nervous system, and bloodstream. Feeling weak and tired, paler skin, bruising, frequent and severe bleeding gums, nasal bleeding; weight loss, shortness of breath, and loss of appetite are all the symptoms of ALL. For ALL treatment, a variety of therapies are used. Chemotherapy is one of the most commonly used treatments in the treatment of ALL.

MARKET SCOPE



The "Global Acute Lymphocytic Leukemia Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the acute lymphocytic leukemia market with detailed market segmentation by type, therapy and distribution channel. The report provides key statistics on the market status of the leading acute lymphocytic leukemia market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on type the market is segmented as, B-cell and T-cell.
  • Based on therapy the market is segmented as, chemotherapy, radiation therapy, bone marrow transplant, targeted therapy and immunotherapy.
  • Based on distribution channel the market is segmented as, hospital pharmacies and retail pharmacies.

MARKET DYNAMICS


Drivers:



  • Increasing incidences of leukemia such as, acute lymphocytic leukemia and lymphoblastic leukemia.
  • Growing awareness about early screening and diagnosis of cancers.
  • Increasing bone marrow biopsies.
  • Growing funding on R&D studies to develop targeted therapies and pipeline for acute lyphocytic leukemia and other haematological disorders.

Restraints:



  • However, presence of stringent regulatory approvals and risk of side effects from the treatment are expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The acute lymphocytic leukemia market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the acute lymphocytic leukemia market in these regions.

IMPACT OF COVID-19 ON ACUTE LYMPHOCYTIC LEUKEMIA MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the acute lymphocytic leukemia market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from acute lymphocytic leukemia market are anticipated to lucrative growth opportunities in the future with the rising demand for acute lymphocytic leukemia in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the acute lymphocytic leukemia market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  • Pfizer, Inc
  • Novartis AG
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd.
  • Acrotech Biopharma, LLC.
  • Erytech Pharma
  • Bristol-Myers Squibb Company
  • Amgen, Inc
  • Leadiant Biosciences, Inc
  • Spectrum Pharmaceuticals, Inc.
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Acute Lymphocytic Leukemia Market - By Type
    1.3.2 Acute Lymphocytic Leukemia Market - By Therapy
    1.3.3 Acute Lymphocytic Leukemia Market - By Distribution Channel
    1.3.4 Acute Lymphocytic Leukemia Market - By Region
    1.3.4.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. ACUTE LYMPHOCYTIC LEUKEMIA MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. ACUTE LYMPHOCYTIC LEUKEMIA MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. ACUTE LYMPHOCYTIC LEUKEMIA MARKET - GLOBAL MARKET ANALYSIS
    6.1. ACUTE LYMPHOCYTIC LEUKEMIA - GLOBAL MARKET OVERVIEW
    6.2. ACUTE LYMPHOCYTIC LEUKEMIA - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. ACUTE LYMPHOCYTIC LEUKEMIA MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
    7.1. OVERVIEW
    7.2. TYPE MARKET FORECASTS AND ANALYSIS
    7.3. B-CELL
    7.3.1. Overview
    7.3.2. B-cell Market Forecast and Analysis
    7.4. T-CELL
    7.4.1. Overview
    7.4.2. T-cell Market Forecast and Analysis
    8. ACUTE LYMPHOCYTIC LEUKEMIA MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY
    8.1. OVERVIEW
    8.2. THERAPY MARKET FORECASTS AND ANALYSIS
    8.3. CHEMOTHERAPY
    8.3.1. Overview
    8.3.2. Chemotherapy Market Forecast and Analysis
    8.4. RADIATION THERAPY
    8.4.1. Overview
    8.4.2. Radiation Therapy Market Forecast and Analysis
    8.5. BONE MARROW TRANSPLANT
    8.5.1. Overview
    8.5.2. Bone Marrow Transplant Market Forecast and Analysis
    8.6. TARGETED THERAPY
    8.6.1. Overview
    8.6.2. Targeted Therapy Market Forecast and Analysis
    8.7. IMMUNOTHERAPY
    8.7.1. Overview
    8.7.2. Immunotherapy Market Forecast and Analysis
    9. ACUTE LYMPHOCYTIC LEUKEMIA MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
    9.1. OVERVIEW
    9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
    9.3. HOSPITAL PHARMACIES
    9.3.1. Overview
    9.3.2. Hospital Pharmacies Market Forecast and Analysis
    9.4. RETAIL PHARMACIES
    9.4.1. Overview
    9.4.2. Retail Pharmacies Market Forecast and Analysis

    10. ACUTE LYMPHOCYTIC LEUKEMIA MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Acute Lymphocytic Leukemia Market Overview
    10.1.2 North America Acute Lymphocytic Leukemia Market Forecasts and Analysis
    10.1.3 North America Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Type
    10.1.4 North America Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Therapy
    10.1.5 North America Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Distribution Channel
    10.1.6 North America Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Acute Lymphocytic Leukemia Market
    10.1.6.1.1 United States Acute Lymphocytic Leukemia Market by Type
    10.1.6.1.2 United States Acute Lymphocytic Leukemia Market by Therapy
    10.1.6.1.3 United States Acute Lymphocytic Leukemia Market by Distribution Channel
    10.1.6.2 Canada Acute Lymphocytic Leukemia Market
    10.1.6.2.1 Canada Acute Lymphocytic Leukemia Market by Type
    10.1.6.2.2 Canada Acute Lymphocytic Leukemia Market by Therapy
    10.1.6.2.3 Canada Acute Lymphocytic Leukemia Market by Distribution Channel
    10.1.6.3 Mexico Acute Lymphocytic Leukemia Market
    10.1.6.3.1 Mexico Acute Lymphocytic Leukemia Market by Type
    10.1.6.3.2 Mexico Acute Lymphocytic Leukemia Market by Therapy
    10.1.6.3.3 Mexico Acute Lymphocytic Leukemia Market by Distribution Channel
    10.2. EUROPE
    10.2.1 Europe Acute Lymphocytic Leukemia Market Overview
    10.2.2 Europe Acute Lymphocytic Leukemia Market Forecasts and Analysis
    10.2.3 Europe Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Type
    10.2.4 Europe Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Therapy
    10.2.5 Europe Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Distribution Channel
    10.2.6 Europe Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Acute Lymphocytic Leukemia Market
    10.2.6.1.1 Germany Acute Lymphocytic Leukemia Market by Type
    10.2.6.1.2 Germany Acute Lymphocytic Leukemia Market by Therapy
    10.2.6.1.3 Germany Acute Lymphocytic Leukemia Market by Distribution Channel
    10.2.6.2 France Acute Lymphocytic Leukemia Market
    10.2.6.2.1 France Acute Lymphocytic Leukemia Market by Type
    10.2.6.2.2 France Acute Lymphocytic Leukemia Market by Therapy
    10.2.6.2.3 France Acute Lymphocytic Leukemia Market by Distribution Channel
    10.2.6.3 Italy Acute Lymphocytic Leukemia Market
    10.2.6.3.1 Italy Acute Lymphocytic Leukemia Market by Type
    10.2.6.3.2 Italy Acute Lymphocytic Leukemia Market by Therapy
    10.2.6.3.3 Italy Acute Lymphocytic Leukemia Market by Distribution Channel
    10.2.6.4 Spain Acute Lymphocytic Leukemia Market
    10.2.6.4.1 Spain Acute Lymphocytic Leukemia Market by Type
    10.2.6.4.2 Spain Acute Lymphocytic Leukemia Market by Therapy
    10.2.6.4.3 Spain Acute Lymphocytic Leukemia Market by Distribution Channel
    10.2.6.5 United Kingdom Acute Lymphocytic Leukemia Market
    10.2.6.5.1 United Kingdom Acute Lymphocytic Leukemia Market by Type
    10.2.6.5.2 United Kingdom Acute Lymphocytic Leukemia Market by Therapy
    10.2.6.5.3 United Kingdom Acute Lymphocytic Leukemia Market by Distribution Channel
    10.2.6.6 Rest of Europe Acute Lymphocytic Leukemia Market
    10.2.6.6.1 Rest of Europe Acute Lymphocytic Leukemia Market by Type
    10.2.6.6.2 Rest of Europe Acute Lymphocytic Leukemia Market by Therapy
    10.2.6.6.3 Rest of Europe Acute Lymphocytic Leukemia Market by Distribution Channel
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Acute Lymphocytic Leukemia Market Overview
    10.3.2 Asia-Pacific Acute Lymphocytic Leukemia Market Forecasts and Analysis
    10.3.3 Asia-Pacific Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Type
    10.3.4 Asia-Pacific Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Therapy
    10.3.5 Asia-Pacific Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Distribution Channel
    10.3.6 Asia-Pacific Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Acute Lymphocytic Leukemia Market
    10.3.6.1.1 Australia Acute Lymphocytic Leukemia Market by Type
    10.3.6.1.2 Australia Acute Lymphocytic Leukemia Market by Therapy
    10.3.6.1.3 Australia Acute Lymphocytic Leukemia Market by Distribution Channel
    10.3.6.2 China Acute Lymphocytic Leukemia Market
    10.3.6.2.1 China Acute Lymphocytic Leukemia Market by Type
    10.3.6.2.2 China Acute Lymphocytic Leukemia Market by Therapy
    10.3.6.2.3 China Acute Lymphocytic Leukemia Market by Distribution Channel
    10.3.6.3 India Acute Lymphocytic Leukemia Market
    10.3.6.3.1 India Acute Lymphocytic Leukemia Market by Type
    10.3.6.3.2 India Acute Lymphocytic Leukemia Market by Therapy
    10.3.6.3.3 India Acute Lymphocytic Leukemia Market by Distribution Channel
    10.3.6.4 Japan Acute Lymphocytic Leukemia Market
    10.3.6.4.1 Japan Acute Lymphocytic Leukemia Market by Type
    10.3.6.4.2 Japan Acute Lymphocytic Leukemia Market by Therapy
    10.3.6.4.3 Japan Acute Lymphocytic Leukemia Market by Distribution Channel
    10.3.6.5 South Korea Acute Lymphocytic Leukemia Market
    10.3.6.5.1 South Korea Acute Lymphocytic Leukemia Market by Type
    10.3.6.5.2 South Korea Acute Lymphocytic Leukemia Market by Therapy
    10.3.6.5.3 South Korea Acute Lymphocytic Leukemia Market by Distribution Channel
    10.3.6.6 Rest of Asia-Pacific Acute Lymphocytic Leukemia Market
    10.3.6.6.1 Rest of Asia-Pacific Acute Lymphocytic Leukemia Market by Type
    10.3.6.6.2 Rest of Asia-Pacific Acute Lymphocytic Leukemia Market by Therapy
    10.3.6.6.3 Rest of Asia-Pacific Acute Lymphocytic Leukemia Market by Distribution Channel
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Acute Lymphocytic Leukemia Market Overview
    10.4.2 Middle East and Africa Acute Lymphocytic Leukemia Market Forecasts and Analysis
    10.4.3 Middle East and Africa Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Type
    10.4.4 Middle East and Africa Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Therapy
    10.4.5 Middle East and Africa Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Distribution Channel
    10.4.6 Middle East and Africa Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Acute Lymphocytic Leukemia Market
    10.4.6.1.1 South Africa Acute Lymphocytic Leukemia Market by Type
    10.4.6.1.2 South Africa Acute Lymphocytic Leukemia Market by Therapy
    10.4.6.1.3 South Africa Acute Lymphocytic Leukemia Market by Distribution Channel
    10.4.6.2 Saudi Arabia Acute Lymphocytic Leukemia Market
    10.4.6.2.1 Saudi Arabia Acute Lymphocytic Leukemia Market by Type
    10.4.6.2.2 Saudi Arabia Acute Lymphocytic Leukemia Market by Therapy
    10.4.6.2.3 Saudi Arabia Acute Lymphocytic Leukemia Market by Distribution Channel
    10.4.6.3 U.A.E Acute Lymphocytic Leukemia Market
    10.4.6.3.1 U.A.E Acute Lymphocytic Leukemia Market by Type
    10.4.6.3.2 U.A.E Acute Lymphocytic Leukemia Market by Therapy
    10.4.6.3.3 U.A.E Acute Lymphocytic Leukemia Market by Distribution Channel
    10.4.6.4 Rest of Middle East and Africa Acute Lymphocytic Leukemia Market
    10.4.6.4.1 Rest of Middle East and Africa Acute Lymphocytic Leukemia Market by Type
    10.4.6.4.2 Rest of Middle East and Africa Acute Lymphocytic Leukemia Market by Therapy
    10.4.6.4.3 Rest of Middle East and Africa Acute Lymphocytic Leukemia Market by Distribution Channel
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Acute Lymphocytic Leukemia Market Overview
    10.5.2 South and Central America Acute Lymphocytic Leukemia Market Forecasts and Analysis
    10.5.3 South and Central America Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Type
    10.5.4 South and Central America Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Therapy
    10.5.5 South and Central America Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Distribution Channel
    10.5.6 South and Central America Acute Lymphocytic Leukemia Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Acute Lymphocytic Leukemia Market
    10.5.6.1.1 Brazil Acute Lymphocytic Leukemia Market by Type
    10.5.6.1.2 Brazil Acute Lymphocytic Leukemia Market by Therapy
    10.5.6.1.3 Brazil Acute Lymphocytic Leukemia Market by Distribution Channel
    10.5.6.2 Argentina Acute Lymphocytic Leukemia Market
    10.5.6.2.1 Argentina Acute Lymphocytic Leukemia Market by Type
    10.5.6.2.2 Argentina Acute Lymphocytic Leukemia Market by Therapy
    10.5.6.2.3 Argentina Acute Lymphocytic Leukemia Market by Distribution Channel
    10.5.6.3 Rest of South and Central America Acute Lymphocytic Leukemia Market
    10.5.6.3.1 Rest of South and Central America Acute Lymphocytic Leukemia Market by Type
    10.5.6.3.2 Rest of South and Central America Acute Lymphocytic Leukemia Market by Therapy
    10.5.6.3.3 Rest of South and Central America Acute Lymphocytic Leukemia Market by Distribution Channel

    11. INDUSTRY LANDSCAPE
    11.1. MERGERS AND ACQUISITIONS
    11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    11.3. NEW PRODUCT LAUNCHES
    11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    12. ACUTE LYMPHOCYTIC LEUKEMIA MARKET, KEY COMPANY PROFILES
    12.1. PFIZER, INC
    12.1.1. Key Facts
    12.1.2. Business Description
    12.1.3. Products and Services
    12.1.4. Financial Overview
    12.1.5. SWOT Analysis
    12.1.6. Key Developments
    12.2. NOVARTIS AG
    12.2.1. Key Facts
    12.2.2. Business Description
    12.2.3. Products and Services
    12.2.4. Financial Overview
    12.2.5. SWOT Analysis
    12.2.6. Key Developments
    12.3. GLAXOSMITHKLINE PLC
    12.3.1. Key Facts
    12.3.2. Business Description
    12.3.3. Products and Services
    12.3.4. Financial Overview
    12.3.5. SWOT Analysis
    12.3.6. Key Developments
    12.4. F. HOFFMANN-LA ROCHE LTD.
    12.4.1. Key Facts
    12.4.2. Business Description
    12.4.3. Products and Services
    12.4.4. Financial Overview
    12.4.5. SWOT Analysis
    12.4.6. Key Developments
    12.5. ACROTECH BIOPHARMA, LLC.
    12.5.1. Key Facts
    12.5.2. Business Description
    12.5.3. Products and Services
    12.5.4. Financial Overview
    12.5.5. SWOT Analysis
    12.5.6. Key Developments
    12.6. ERYTECH PHARMA
    12.6.1. Key Facts
    12.6.2. Business Description
    12.6.3. Products and Services
    12.6.4. Financial Overview
    12.6.5. SWOT Analysis
    12.6.6. Key Developments
    12.7. BRISTOL-MYERS SQUIBB COMPANY
    12.7.1. Key Facts
    12.7.2. Business Description
    12.7.3. Products and Services
    12.7.4. Financial Overview
    12.7.5. SWOT Analysis
    12.7.6. Key Developments
    12.8. AMGEN, INC
    12.8.1. Key Facts
    12.8.2. Business Description
    12.8.3. Products and Services
    12.8.4. Financial Overview
    12.8.5. SWOT Analysis
    12.8.6. Key Developments
    12.9. LEADIANT BIOSCIENCES, INC
    12.9.1. Key Facts
    12.9.2. Business Description
    12.9.3. Products and Services
    12.9.4. Financial Overview
    12.9.5. SWOT Analysis
    12.9.6. Key Developments
    12.10. SPECTRUM PHARMACEUTICALS, INC.
    12.10.1. Key Facts
    12.10.2. Business Description
    12.10.3. Products and Services
    12.10.4. Financial Overview
    12.10.5. SWOT Analysis
    12.10.6. Key Developments

    13. APPENDIX
    13.1. ABOUT THE INSIGHT PARTNERS
    13.2. GLOSSARY OF TERMS
    The List of Companies

    - Pfizer, Inc
    - Novartis AG
    - GlaxoSmithKline plc
    - F. Hoffmann-La Roche Ltd.
    - Acrotech Biopharma, LLC.
    - Erytech Pharma
    - Bristol-Myers Squibb Company
    - Amgen, Inc
    - Leadiant Biosciences, Inc
    - Spectrum Pharmaceuticals, Inc.
    - Genmab A/S
    - Takeda Pharmaceutical Company Limited
    TIPRE00004060
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking
    Request for Sample
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.